AstraZeneca to seek US approval of COVID vaccine in 2nd halfAstraZeneca to seek US approval of COVID vaccine in 2nd halfAstraZeneca to seek US approval of COVID vaccine in 2nd half

AstraZeneca to seek US approval of COVID vaccine in 2nd half

AstraZeneca said it has decided to ask the U.S. Food and Drug Administration for full regulatory approval of the vaccine, rather than the fast-track emergency use authorization originally anticipated.

from Section Page News - Modern Healthcare https://ift.tt/378B0zy